Conventional magnetic resonance imaging–based radiomic signature predicts telomerase reverse transcriptase promoter mutation status in grade II and III gliomas.

Purpose: Telomerase reverse transcriptase (TERT) promoter mutation status is an important biomarker for the precision diagnosis and prognosis prediction of lower grade glioma (LGG). This study aimed to construct a radiomic signature to noninvasively predict the TERT promoter status in LGGs. Methods:...

Descripción completa

Detalles Bibliográficos
Publicado en:Neuroradiology Vol. 62; no. 7; pp. 803 - 814
Autores principales: Jiang, Chendan, Kong, Ziren, Zhang, Yiwei, Liu, Sirui, Liu, Zeyu, Chen, Wenlin, Liu, Penghao, Liu, Delin, Wang, Yaning, Lyu, Yuelei, Zhao, Dachun, Wang, Yu, You, Hui, Feng, Feng, Ma, Wenbin
Formato: diagnostic images research tables/charts Journal Article
Publicado: Springer Nature Jul2020
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=144203159&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 144203159
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        00283940
        NYZ
      jtl: Neuroradiology
      issn: 00283940
      maglogo: N
    pubinfo:
      dt: Jul2020
      vid: 62
      iid: 7
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        144203159
        144183168
        144203159
        144203159
        10.1007/s00234-020-02392-1
        144203159
      ppf: 803
      ppct: 11
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Conventional magnetic resonance imaging–based radiomic signature predicts telomerase reverse transcriptase promoter mutation status in grade II and III gliomas.
      aug:
        au:
          Jiang, Chendan
          Kong, Ziren
          Zhang, Yiwei
          Liu, Sirui
          Liu, Zeyu
          Chen, Wenlin
          Liu, Penghao
          Liu, Delin
          Wang, Yaning
          Lyu, Yuelei
          Zhao, Dachun
          Wang, Yu
          You, Hui
          Feng, Feng
          Ma, Wenbin
        affil: Department of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
      sug:
        subj:
          Magnetic Resonance Imaging Methods
          Algorithms
          Telomerase
          Promoters
          Mutation
          Neoplasm Grading
          Glioma Familial and Genetic
          Human
          Male
          Cancer Patients
          Retrospective Design
          ROC Curve
          Descriptive Statistics
          Sensitivity and Specificity
          Comparative Studies
          Male
      ab: Purpose: Telomerase reverse transcriptase (TERT) promoter mutation status is an important biomarker for the precision diagnosis and prognosis prediction of lower grade glioma (LGG). This study aimed to construct a radiomic signature to noninvasively predict the TERT promoter status in LGGs. Methods: Eighty-three local patients with pathology-confirmed LGG were retrospectively included as a training cohort, and 33 patients from The Cancer Imaging Archive (TCIA) were used as for independent validation. Three types of regions of interest (ROIs), which covered the tumor, peri-tumoral area, and tumor plus peri-tumoral area, were delineated on three-dimensional contrast-enhanced T1 (3D-CE-T1)-weighted and T2-weighted images. One hundred seven shape, first-order, and texture radiomic features from each modality under each ROI were extracted and selected through least absolute shrinkage and selection operator. Radiomic signatures were constructed with multiple classifiers and evaluated using receiver operating characteristic (ROC) analysis. The tumors were also stratified according to IDH status. Results: Three radiomic signatures, namely, tumoral radiomic signature, tumoral plus peri-tumoral radiomic signature, and fusion radiomic signature, were built, all of which exhibited good accuracy and balanced sensitivity and specificity. The tumoral signature displayed the best performance, with area under the ROC curves (AUC) of 0.948 (0.903–0.993) in the training cohort and 0.827 (0.667–0.988) in the validation cohort. In the IDH subgroups, the AUCs of the tumoral signature ranged from 0.750 to 0.940. Conclusion: The MRI-based radiomic signature is reliable for noninvasive evaluation of TERT promoter mutations in LGG regardless of the IDH status. The inclusion of peri-tumoral area did not significantly improve the performance.
      pubtype: Academic Journal
      doctype:
        diagnostic images
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N